Company / Capital Returned to Shareholders per Share
Integra Lifesciences Holdings Capital Returned to Shareholders per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.00
FY2025
5-year range
$0.00 / $3.22
FY2021-FY2025
Trend
-99.6%
vs FY2024
Sector context
#95 of 108
Health Care
What the data says
Integra Lifesciences Holdings's capital returned to shareholders per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2021 to $3.22 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -70.3%.
Declined from $3.22 to $0.00 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -87.7%
- 5-Year CAGR
- -70.3%
- 10-Year CAGR
- -
Sector benchmark
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 99.6% year-over-year.
- Ranks #95 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2023.
- Lowest capital returned to shareholders per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -99.6% |
| FY2024 | $0.63 | -80.5% |
| FY2023 | $3.22 | +119.3% |
| FY2022 | $1.47 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $1.19 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026